Literature DB >> 19017978

RGS13 controls g protein-coupled receptor-evoked responses of human mast cells.

Geetanjali Bansal1, Jeffrey A DiVietro, Hye Sun Kuehn, Sudhir Rao, Karl H Nocka, Alasdair M Gilfillan, Kirk M Druey.   

Abstract

IgE-mediated mast cell degranulation and release of vasoactive mediators induced by allergens elicits allergic responses. Although G protein-coupled receptor (GPCR)-induced signals may amplify IgE-dependent degranulation, how GPCR signaling in mast cells is regulated remains incompletely defined. We investigated the role of regulator of G protein signaling (RGS) proteins in the modulation of these pathways in human mast cells. Several RGS proteins were expressed in mast cells including RGS13, which we previously showed inhibited IgE-mediated mast cell degranulation and anaphylaxis in mice. To characterize how RGS13 affects GPCR-mediated functions of human mast cells, we analyzed human mast cell lines (HMC-1 and LAD2) depleted of RGS13 by specific small interfering RNA or short hairpin RNA and HMC-1 cells overexpressing RGS13. Transient RGS13 knockdown in LAD2 cells lead to increased degranulation to sphingosine-1-phosphate but not to IgE-Ag or C3a. Relative to control cells, HMC-1 cells stably expressing RGS13-targeted short hairpin RNA had greater Ca(2+) mobilization in response to several natural GPCR ligands such as adenosine, C5a, sphingosine-1-phosphate, and CXCL12 than wild-type cells. Akt phosphorylation, chemotaxis, and cytokine (IL-8) secretion induced by CXCL12 were also greater in short hairpin RGS13-HMC-1 cells compared with control. RGS13 overexpression inhibited CXCL12-evoked Ca(2+) mobilization, Akt phosphorylation and chemotaxis. These results suggest that RGS13 restricts certain GPCR-mediated biological responses of human mast cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017978      PMCID: PMC2693264          DOI: 10.4049/jimmunol.181.11.7882

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin.

Authors:  M Juremalm; M Hjertson; N Olsson; I Harvima; K Nilsson; G Nilsson
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

2.  Regulation of T cell activation, anxiety, and male aggression by RGS2.

Authors:  A J Oliveira-Dos-Santos; G Matsumoto; B E Snow; D Bai; F P Houston; I Q Whishaw; S Mariathasan; T Sasaki; A Wakeham; P S Ohashi; J C Roder; C A Barnes; D P Siderovski; J M Penninger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation.

Authors:  Jianming Hao; Christina Michalek; Wei Zhang; Ming Zhu; Xiaomei Xu; Ulrike Mende
Journal:  J Mol Cell Cardiol       Date:  2006-06-06       Impact factor: 5.000

4.  Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosine-mediated chronotropic effects.

Authors:  Ying Fu; Xinyan Huang; Huailing Zhong; Richard M Mortensen; Louis G D'Alecy; Richard R Neubig
Journal:  Circ Res       Date:  2006-02-02       Impact factor: 17.367

5.  RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization.

Authors:  Jang-Il Han; Ning-Na Huang; Dong-Uk Kim; John H Kehrl
Journal:  J Leukoc Biol       Date:  2006-03-24       Impact factor: 4.962

6.  Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells.

Authors:  Sergey Ryzhov; Anna E Goldstein; Italo Biaggioni; Igor Feoktistov
Journal:  Mol Pharmacol       Date:  2006-05-17       Impact factor: 4.436

7.  Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.

Authors:  H Ali; J Ahamed; C Hernandez-Munain; J L Baron; M S Krangel; D D Patel
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

8.  Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha.

Authors:  T J Lin; T B Issekutz; J S Marshall
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

9.  RGS13 acts as a nuclear repressor of CREB.

Authors:  Zhihui Xie; Timothy R Geiger; Eric N Johnson; Jennifer K Nyborg; Kirk M Druey
Journal:  Mol Cell       Date:  2008-09-05       Impact factor: 17.970

10.  Akt-dependent cytokine production in mast cells.

Authors:  J Kitaura; K Asai; M Maeda-Yamamoto; Y Kawakami; U Kikkawa; T Kawakami
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

View more
  23 in total

1.  Beta-agonist-associated reduction in RGS5 expression promotes airway smooth muscle hyper-responsiveness.

Authors:  Zhao Yang; Philip R Cooper; Gautam Damera; Indranil Mukhopadhyay; Hyeseon Cho; John H Kehrl; Reynold A Panettieri; Kirk M Druey
Journal:  J Biol Chem       Date:  2011-01-29       Impact factor: 5.157

2.  Phosphorylation of RGS13 by the cyclic AMP-dependent protein kinase inhibits RGS13 degradation.

Authors:  Zhihui Xie; Zhao Yang; Kirk M Druey
Journal:  J Mol Cell Biol       Date:  2010-10-25       Impact factor: 6.216

3.  RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation.

Authors:  Jesse W Williams; Douglas Yau; Nan Sethakorn; Jacob Kach; Eleanor B Reed; Tamson V Moore; Judy Cannon; Xiaohua Jin; Heming Xing; Anthony J Muslin; Anne I Sperling; Nickolai O Dulin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-27       Impact factor: 5.464

4.  p53 negatively regulates RGS13 protein expression in immune cells.

Authors:  Shoko Iwaki; Yunbiao Lu; Zhihui Xie; Kirk M Druey
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

5.  Redefinition of the human mast cell transcriptome by deep-CAGE sequencing.

Authors:  Efthymios Motakis; Sven Guhl; Yuri Ishizu; Masayoshi Itoh; Hideya Kawaji; Michiel de Hoon; Timo Lassmann; Piero Carninci; Yoshihide Hayashizaki; Torsten Zuberbier; Alistair R R Forrest; Magda Babina
Journal:  Blood       Date:  2014-03-26       Impact factor: 22.113

Review 6.  Regulator of G protein signaling 10: Structure, expression and functions in cellular physiology and diseases.

Authors:  Faris Almutairi; Jae-Kyung Lee; Balázs Rada
Journal:  Cell Signal       Date:  2020-08-31       Impact factor: 4.315

7.  Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma.

Authors:  Xiaoyu Sun; Tianheng Hou; Edwin Cheung; Tiffany Nga-Teng Iu; Victor Wai-Hou Tam; Ida Miu-Ting Chu; Miranda Sin-Man Tsang; Paul Kay-Sheung Chan; Christopher Wai-Kei Lam; Chun-Kwok Wong
Journal:  Cell Mol Immunol       Date:  2019-10-23       Impact factor: 11.530

8.  Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs.

Authors:  I Y Hwang; C Park; K A Harrision; N N Huang; J H Kehrl
Journal:  Genes Immun       Date:  2010-05-27       Impact factor: 2.676

Review 9.  R4 Regulator of G Protein Signaling (RGS) Proteins in Inflammation and Immunity.

Authors:  Zhihui Xie; Eunice C Chan; Kirk M Druey
Journal:  AAPS J       Date:  2015-11-23       Impact factor: 4.009

10.  Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset.

Authors:  Ana Olivera; Sandra E Dillahunt; Juan Rivera
Journal:  Immunol Lett       Date:  2013-01-18       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.